Robert Przynosch, DPM
Podiatrist · Waynesville, NCNPI 1568439073
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,189 of the $8,889 with a category attached, or 69.6%. It is spread thinly across 32 manufacturers, the largest accounting for just 15.7%. Reporting peaked in 2020 at $2,170 and has fallen 61.2% since, to $841 in 2025. Among podiatrist clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $40.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Peerless Surgical Inc.$1K
- Stryker$1K
- Treace Medical Concepts, Inc.$1K
- Smith+Nephew$1K
- Averitas Pharma Inc.$546
- Amgen$493
- plus $3K from 26 others
What the payments were for
- Travel & lodging$1,30415%
- Food & beverage$6,18970%
- Education$1,39616%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Peerless Surgical Inc. | 1 | $1,396 |
| Stryker(2 entities) | 19 | $1,383 |
| Treace Medical Concepts, Inc. | 18 | $1,188 |
| Smith+Nephew | 42 | $1,022 |
| Averitas Pharma Inc. | 49 | $546 |
| Amgen(2 entities) | 12 | $493 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $467 |
| Paratek Pharmaceuticals, Inc. | 11 | $391 |
| Organogenesis Inc. | 9 | $381 |
| Next Science LLC | 3 | $224 |
| Acera Surgical, Inc. | 3 | $188 |
| Nevro Corp. | 4 | $160 |
| Bioventus LLC | 3 | $147 |
| GRT US Holding, Inc. | 9 | $118 |
| Kerecis Limited | 6 | $115 |
| Convatec Inc. | 6 | $115 |
| Amniox Medical, Inc. | 1 | $100 |
| Johnson & Johnson | 1 | $80 |
| Biocomposites Inc | 1 | $67 |
| KCI USA, Inc. | 3 | $51 |
| Medtronic | 2 | $46 |
| Paragon 28, Inc. | 2 | $32 |
| Tactile Systems Technology Inc | 2 | $32 |
| Aroa Biosurgery Incorporated | 1 | $28 |
| Linvatec Corporation | 1 | $20 |
| Zimmer Biomet | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Hartmann USA, Inc. | 1 | $15 |
| Mimedx Group, Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $14 |
| Solventum Corporation | 1 | $13 |
| Boston Scientific | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,889 in reported general payments places this provider in the 90th percentile of 109 podiatrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KrystexxaPegloticase | 15 | $418,254 |
| Pregabalin | 60 | $1,526 |
| Allopurinol | 111 | $1,113 |
| Gabapentin | 123 | $1,085 |
| Colchicine | 23 | $908 |
| Terbinafine Hcl | 39 | $741 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $485 |
| Silver Sulfadiazine | 46 | $298 |
| Cephalexin | 38 | $265 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $261 |
| Ciclopirox | 14 | $259 |
| Doxycycline Hyclate | 22 | $217 |
| Celecoxib | 12 | $182 |
| Mupirocin | 23 | $166 |
| Ibuprofen | 19 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenKrystexxa | $493 | $418,25415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 109 podiatrist providers in North Carolina.
Other podiatrist in Waynesville
- William BanksWaynesville$9K
- Robert DelbeneWaynesville$3K
- Matthew DavisWaynesville$2K
- Jordan MeyersRaleigh$343K
- Christopher GaulandGreenville$56K
- Scott MartinRocky Mount$14K
- Gretchen LawrenceForest City$12K
- William WeilyCharlotte$11K
- Kristin KirbyHuntersville$10K
- Emily LobosAsheville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.